X
Aug 01, 2021 04:44 PM (GMT+8) · EqualOcean
Shutaishen announced that the company recently publicized the phase II clinical trial information of coagulation factor X activator "stsp-0601 for injection" on the drug clinical trial registration and information publicity platform of the State Drug Administration.